Heart failure due to Chagas cardiomyopathy (HFCC) differs from failure with other etiologies because of the occurrence of intense inflammatory infiltrate and right ventricle compromise. This article investigates correlations of B-type natriuretic peptide (BNP) levels with parameters of severity in HFCC. Twenty-eight patients and 8 normal controls underwent heart catheterization and clinical and laboratory analyses. BNP levels were higher in patients with HFCC (P<.0001) and correlated with New York Heart Association (NYHA) class; right atrial pressure; wedge pressure; cardiac output; levels of serum sodium, hemoglobin, urea, and tumor necrosis factor-alpha; and ejection fraction. Interferon-gamma and transforming growth factor-beta did not c...
Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with heart fail...
Copyright © 2013 Aftab Jan et al.This is an open access article distributed under the Creative Commo...
Background Chronic Chagas Cardiomyopathy (CCM) is a unique form of cardiomyopathy compared to other ...
Chagas’ disease, caused by the protozoan Trypanosoma cruzi, remains a leading cause of heart disease...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Since from the last one decade, new cardiac biomarkers specifically BNP levels are being used widely...
Chagas disease remains a major cause of mortality in several countries of La...
INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin Americ...
OBJECTIVE: Chronic Chagas disease afflicts millions of patients in Latin America of which 70% remain...
Copyright © 2015 Laura Leto et al. This is an open access article distributed under the Creative Com...
Background—In patients with symptoms of heart failure, elevations in B-type natriuretic peptide (BNP...
UnlabelledMarked elevations of B-type natriuretic peptide (BNP) are not generally seen in patients w...
Brain natriuretic peptide (BNP), a neurohormone secreted from the ventricular myocardium in response...
Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with heart fail...
Copyright © 2013 Aftab Jan et al.This is an open access article distributed under the Creative Commo...
Background Chronic Chagas Cardiomyopathy (CCM) is a unique form of cardiomyopathy compared to other ...
Chagas’ disease, caused by the protozoan Trypanosoma cruzi, remains a leading cause of heart disease...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortal...
Since from the last one decade, new cardiac biomarkers specifically BNP levels are being used widely...
Chagas disease remains a major cause of mortality in several countries of La...
INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin Americ...
OBJECTIVE: Chronic Chagas disease afflicts millions of patients in Latin America of which 70% remain...
Copyright © 2015 Laura Leto et al. This is an open access article distributed under the Creative Com...
Background—In patients with symptoms of heart failure, elevations in B-type natriuretic peptide (BNP...
UnlabelledMarked elevations of B-type natriuretic peptide (BNP) are not generally seen in patients w...
Brain natriuretic peptide (BNP), a neurohormone secreted from the ventricular myocardium in response...
Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with heart fail...
Copyright © 2013 Aftab Jan et al.This is an open access article distributed under the Creative Commo...
Background Chronic Chagas Cardiomyopathy (CCM) is a unique form of cardiomyopathy compared to other ...